Quantcast

Drug Manufacturer Watson Sues FDA Over Generic Actos Release

Watson Pharmaceuticals has filed a lawsuit against the FDA for denying shared exclusivity, despite the fact that the drug company followed all the FDA’s requirements. Watson planned to release the generic version of Takeda Pharmaceutical’s controversial Actos drug on August 17th. In 2010, Watson got approval to market the generic pioglitazone … [Read more...]

Study Reveals Obesity Rates in the South are Some of Highest in the Country; South Carolina Places 8th

A new study shows that 12 states have obesity rates higher than 30%, and 26 of the 30 states with high obesity rates are in the South and Midwest. South Carolina ranks number 8 in the study, with an obesity rate of 30.8%. Five years ago, South Carolina ranked 10th in the nation, with between three or four people dying each day from diabetes and … [Read more...]

Actos Increases Bladder Cancer Risk Compared to Different Class of Diabetes Drugs

A new study released earlier this month, and published in the Journal of the National Cancer Institute, found that thiazolidinedione (TZD) drugs like Actos were more likely to cause bladder cancer than a different class of drugs called sulfonylurea drugs. Patients who took TZD drugs were two to three times more likely to develop bladder cancer than … [Read more...]

Actos Bellwether Cases Scheduled for MDL 2299

Presiding Judge Rebecca Doherty has issued a detailed schedule for proceedings in the Actos Multidistrict Litigation (MDL) 2299. Bellwether trials, which are typical in MDLs, are early trials designed by both parties to gauge the juries’ reactions to evidence. The trials picked as bellwether cases normally represent egregious cases. Attorneys … [Read more...]

Women At Greater Risk of Developing Type 2 Diabetes

A recent study of diabetes and job stress showed that women who were micromanaged were at greater risk of developing Type 2 diabetes than their male counterparts. However, job stress is not the only thing that increases professional women’s risk of diabetes. Peter Smith, lead author of the nine-year study by researchers at the Institute for Work … [Read more...]

10,000 Lawsuits: Actos Injury Filing in Multidistrict Litigation 2299 Streamlined

Judge Rebecca Doherty signed a Direct Filing Order in April that allows any plaintiff to add their lawsuit directly to Actos Multidistrict Litigation 2299. In December 2011, a federal Judicial Panel consolidated several Actos lawsuits under one federal court, in Lafayette, Louisiana. The Honorable Rebecca Doherty is presiding over the … [Read more...]

Actos Linked to Vision Problems and Blindness

Takeda Pharmaceuticals currently faces hundreds of lawsuits for detrimental side effects of its popular diabetes drug Actos, which has been linked to an increased risk of bladder cancer. In the midst of this whirlwind, a new 10-year study has linked Actos, and its rival Avandia, to an increased risk of diabetic macular edema. Macular edema occurs … [Read more...]

Skip Generic Actos, for Health and Legal Reasons

Earlier this month, despite numerous lawsuits against Takeda Pharmaceuticals Actos, the FDA approved pioglitazone – the generic name for Actos – for market in the United States. Now, watchdog group Consumer Reports says the “bargain” should be avoided. For one thing, Consumer Reports points out, the generic version will not currently save patients … [Read more...]

Judge Doherty extends deadline to file against Actos in MDL 2299

Judge Rebecca Doherty, who is overseeing the Actos multidistrict litigation (MDL) suit 2299 in Louisiana, extended the deadline for plaintiffs to file suits against Takeda Pharmaceuticals. Judge Doherty cited the large number of cases expected to be filed, and the necessity of gathering enough information in each case. She issued a scheduling … [Read more...]

Along with Bladder Cancer, Actos Can Also Cause Bone Fractures

Women Who Took Actos for Diabetes More Susceptible to Bone Fractures Takeda Pharmaceuticals’ Type 2 diabetes drug, Actos, has been the focus of hundreds of personal injury lawsuits for at least two years. The lawsuits were combined into one multidistrict litigation, MDL 2299, in the court of Louisiana (Lafayette) – the Honorable Rebecca Doherty … [Read more...]

BestLawyers.comAVBetter Business Bureau